![](/img/cover-not-exists.png)
Importance of dose intensity in neurooncology clinical trials: SummaryReport of the Sixth Annual Meeting of the Blood-Brain Barrier DisruptionConsortium
Doolittle, N. D., Anderson, C. P., Bleyer, W. A., Cairncross, J. G., Cloughesy, T., Eck, S. L., Guastadisegni, P., Hall, W. A., Muldoon, L. L., Patel, S. J., Peereboom, D., Siegal, T., Neuwelt, E. A.Volume:
3
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/3.1.46
Date:
January, 2001
File:
PDF, 118 KB
english, 2001